Evidence of a role for NK cells in oxazaphosphorine-mediated tumor regression View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1989-11

AUTHORS

Thomas Reissmann, Peter Hilgard, Rainer Voegeli, Jens Zeller

ABSTRACT

The present studies showed that nude mice xenotransplanted with L5222 leukemia responded as did syngeneic BD IX rats to low doses of mafosfamide or cyclophosphamide. Unlike rats, nude mice rarely showed resistance to a second tumor challenge. The observation that concurrent treatment of rats with cyclosporin A did not alter the rate of survival clearly indicated a T-cell-independent mechanism of tumor defense. The incidence of lung colonies from i.v. injected Lewis lung-tumor cells could be enhanced by a high dose pretreatment with mafosfamide or cyclophosphamide, whereas pretreatment at low doses was inhibitory. Since identical experiments carried out in NK-cell-deficient C57Bl/6 "beige" mice did not show such an effect, NK cells appeared to represent a possible effector cell in oxazaphosphorine-mediated antitumor effects. This assumption was further supported by the fact that enhanced NK cell activity could be observed in the 51Cr release assay using spleen cells from mafosfamide-treated L5222-bearing rats. The transplantation of the unrelated syngeneic ovarian carcinoma OV-342 to animals that had previously been cured of L5222 leukemia did not lead to the rejection of this tumor. This indicates that a specific resistance against L5222 leukemia had developed. In contrast, a T-cell-dependent antitumor effect was demonstrated for mafosfamide in the MOPC-315 mouse plasmocytoma. Therefore, we conclude that the effector cell for tumor rejection depends on the type of tumor. This, of course, does not exclude a common target cell for the immunopharmacological activity of oxazaphosphorines. More... »

PAGES

525-530

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf00391352

DOI

http://dx.doi.org/10.1007/bf00391352

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1001265313

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/2606928


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclophosphamide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclosporins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytotoxicity, Immunologic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Killer Cells, Natural", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukemia, Experimental", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice, Inbred Strains", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice, Nude", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ovarian Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Plasmacytoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Cells, Cultured", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Department of Experimental Cancer Research, ASTA Pharma AG, D-4800, Bielefeld 14, Federal Republic of Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Reissmann", 
        "givenName": "Thomas", 
        "id": "sg:person.01340535776.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340535776.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Experimental Cancer Research, ASTA Pharma AG, D-4800, Bielefeld 14, Federal Republic of Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hilgard", 
        "givenName": "Peter", 
        "id": "sg:person.01023655171.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023655171.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Experimental Cancer Research, ASTA Pharma AG, D-4800, Bielefeld 14, Federal Republic of Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Voegeli", 
        "givenName": "Rainer", 
        "id": "sg:person.0633453775.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0633453775.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "German Cancer Research Center", 
          "id": "https://www.grid.ac/institutes/grid.7497.d", 
          "name": [
            "Institute for Toxicology and Chemotherapy, Deutsches Krebsforschungszentrum, D-6900, Heidelberg, Federal Republic of Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zeller", 
        "givenName": "Jens", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf01631649", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000151847", 
          "https://doi.org/10.1007/bf01631649"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.2910150408", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002471216"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(19860615)57:12<2309::aid-cncr2820571212>3.0.co;2-h", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004798902"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0192-0561(85)90016-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009463786"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0192-0561(85)90016-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009463786"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1084/jem.155.1.276", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012689937"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/278451a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013138905", 
          "https://doi.org/10.1038/278451a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00204986", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025873521", 
          "https://doi.org/10.1007/bf00204986"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00204986", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025873521", 
          "https://doi.org/10.1007/bf00204986"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0192-0561(86)90098-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026508026"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0192-0561(86)90098-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026508026"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1084/jem.161.5.1249", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031090006"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00205439", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035713745", 
          "https://doi.org/10.1007/bf00205439"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00205439", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035713745", 
          "https://doi.org/10.1007/bf00205439"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00047471", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046220680", 
          "https://doi.org/10.1007/bf00047471"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00047471", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046220680", 
          "https://doi.org/10.1007/bf00047471"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00205559", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052450309", 
          "https://doi.org/10.1007/bf00205559"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00205559", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052450309", 
          "https://doi.org/10.1007/bf00205559"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/262077a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053098476", 
          "https://doi.org/10.1038/262077a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.7025208", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062643291"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079645222", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079661323", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079719452", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079745935", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/78.4.735", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079768676"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079909305", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1080029033", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1081632263", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082079384", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082165067", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082270364", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1989-11", 
    "datePublishedReg": "1989-11-01", 
    "description": "The present studies showed that nude mice xenotransplanted with L5222 leukemia responded as did syngeneic BD IX rats to low doses of mafosfamide or cyclophosphamide. Unlike rats, nude mice rarely showed resistance to a second tumor challenge. The observation that concurrent treatment of rats with cyclosporin A did not alter the rate of survival clearly indicated a T-cell-independent mechanism of tumor defense. The incidence of lung colonies from i.v. injected Lewis lung-tumor cells could be enhanced by a high dose pretreatment with mafosfamide or cyclophosphamide, whereas pretreatment at low doses was inhibitory. Since identical experiments carried out in NK-cell-deficient C57Bl/6 \"beige\" mice did not show such an effect, NK cells appeared to represent a possible effector cell in oxazaphosphorine-mediated antitumor effects. This assumption was further supported by the fact that enhanced NK cell activity could be observed in the 51Cr release assay using spleen cells from mafosfamide-treated L5222-bearing rats. The transplantation of the unrelated syngeneic ovarian carcinoma OV-342 to animals that had previously been cured of L5222 leukemia did not lead to the rejection of this tumor. This indicates that a specific resistance against L5222 leukemia had developed. In contrast, a T-cell-dependent antitumor effect was demonstrated for mafosfamide in the MOPC-315 mouse plasmocytoma. Therefore, we conclude that the effector cell for tumor rejection depends on the type of tumor. This, of course, does not exclude a common target cell for the immunopharmacological activity of oxazaphosphorines.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/bf00391352", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1313647", 
        "issn": [
          "0171-5216", 
          "1432-1335"
        ], 
        "name": "Journal of Cancer Research and Clinical Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "115"
      }
    ], 
    "name": "Evidence of a role for NK cells in oxazaphosphorine-mediated tumor regression", 
    "pagination": "525-530", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "0606c90f1eab6102a69eadaa320ae571091630d59c0e780247e7f5c5b488fa80"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "2606928"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7902060"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf00391352"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1001265313"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf00391352", 
      "https://app.dimensions.ai/details/publication/pub.1001265313"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:55", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000371_0000000371/records_130814_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/BF00391352"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf00391352'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf00391352'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf00391352'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf00391352'


 

This table displays all metadata directly associated to this object as RDF triples.

231 TRIPLES      21 PREDICATES      70 URIs      37 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf00391352 schema:about N03abb4870081400abcd246a5b19e6802
2 N1d8b7225fde1496ab674e6a58e28ee61
3 N3bcaf7bc7f2043dab58bbd96800e7307
4 N44250bd86e674ba9bb6d8e82e7cb8361
5 N451574304078481f8dc6c25300b1a5e0
6 N4e18727c479d49ed96c4a8a0c4c21adb
7 N68374052020c436bbb57d277aa976860
8 N8715cba4a3ee4faab9a72d404675299d
9 Na69f3e95d8034dec83027315292c4743
10 Nbe046f89f97c41f49ede079c837b727c
11 Nc79dfdb85d4b4f0e8adea88061a9fef0
12 Nc80d4b6122d84a39a69452839dafb1cc
13 Nc8776455244248f6b94d824bdae46980
14 Ne3028014ef3e415e9a16fdee78608d59
15 Nf05e47c4f6614a22a8900c2ff0713710
16 Nf94e8de29dde4304a0484e083deb609f
17 anzsrc-for:11
18 anzsrc-for:1107
19 schema:author N62b73f8678de45dcb5e6a2f8496c012a
20 schema:citation sg:pub.10.1007/bf00047471
21 sg:pub.10.1007/bf00204986
22 sg:pub.10.1007/bf00205439
23 sg:pub.10.1007/bf00205559
24 sg:pub.10.1007/bf01631649
25 sg:pub.10.1038/262077a0
26 sg:pub.10.1038/278451a0
27 https://app.dimensions.ai/details/publication/pub.1079645222
28 https://app.dimensions.ai/details/publication/pub.1079661323
29 https://app.dimensions.ai/details/publication/pub.1079719452
30 https://app.dimensions.ai/details/publication/pub.1079745935
31 https://app.dimensions.ai/details/publication/pub.1079909305
32 https://app.dimensions.ai/details/publication/pub.1080029033
33 https://app.dimensions.ai/details/publication/pub.1081632263
34 https://app.dimensions.ai/details/publication/pub.1082079384
35 https://app.dimensions.ai/details/publication/pub.1082165067
36 https://app.dimensions.ai/details/publication/pub.1082270364
37 https://doi.org/10.1002/1097-0142(19860615)57:12<2309::aid-cncr2820571212>3.0.co;2-h
38 https://doi.org/10.1002/ijc.2910150408
39 https://doi.org/10.1016/0192-0561(85)90016-5
40 https://doi.org/10.1016/0192-0561(86)90098-6
41 https://doi.org/10.1084/jem.155.1.276
42 https://doi.org/10.1084/jem.161.5.1249
43 https://doi.org/10.1093/jnci/78.4.735
44 https://doi.org/10.1126/science.7025208
45 schema:datePublished 1989-11
46 schema:datePublishedReg 1989-11-01
47 schema:description The present studies showed that nude mice xenotransplanted with L5222 leukemia responded as did syngeneic BD IX rats to low doses of mafosfamide or cyclophosphamide. Unlike rats, nude mice rarely showed resistance to a second tumor challenge. The observation that concurrent treatment of rats with cyclosporin A did not alter the rate of survival clearly indicated a T-cell-independent mechanism of tumor defense. The incidence of lung colonies from i.v. injected Lewis lung-tumor cells could be enhanced by a high dose pretreatment with mafosfamide or cyclophosphamide, whereas pretreatment at low doses was inhibitory. Since identical experiments carried out in NK-cell-deficient C57Bl/6 "beige" mice did not show such an effect, NK cells appeared to represent a possible effector cell in oxazaphosphorine-mediated antitumor effects. This assumption was further supported by the fact that enhanced NK cell activity could be observed in the 51Cr release assay using spleen cells from mafosfamide-treated L5222-bearing rats. The transplantation of the unrelated syngeneic ovarian carcinoma OV-342 to animals that had previously been cured of L5222 leukemia did not lead to the rejection of this tumor. This indicates that a specific resistance against L5222 leukemia had developed. In contrast, a T-cell-dependent antitumor effect was demonstrated for mafosfamide in the MOPC-315 mouse plasmocytoma. Therefore, we conclude that the effector cell for tumor rejection depends on the type of tumor. This, of course, does not exclude a common target cell for the immunopharmacological activity of oxazaphosphorines.
48 schema:genre research_article
49 schema:inLanguage en
50 schema:isAccessibleForFree false
51 schema:isPartOf N218f24fd2ec0472e8fa1bf90fba6915b
52 Nc8234753752c497cbf2252597d10c934
53 sg:journal.1313647
54 schema:name Evidence of a role for NK cells in oxazaphosphorine-mediated tumor regression
55 schema:pagination 525-530
56 schema:productId N6f9880a502cc4b939934dacaea6e56f6
57 Nb975b8467fef4e64adfcb9b601445fb8
58 Nd2f2bac8c60c40b1b98d048e2c37a90b
59 Nd851f0527d6640eaac9e41b7eea1d133
60 Ne653a2eb56d142bd844d6bec0e9a7791
61 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001265313
62 https://doi.org/10.1007/bf00391352
63 schema:sdDatePublished 2019-04-11T13:55
64 schema:sdLicense https://scigraph.springernature.com/explorer/license/
65 schema:sdPublisher Naffdf794cb32424a8e0dbbfa5e97568b
66 schema:url http://link.springer.com/10.1007/BF00391352
67 sgo:license sg:explorer/license/
68 sgo:sdDataset articles
69 rdf:type schema:ScholarlyArticle
70 N03abb4870081400abcd246a5b19e6802 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Leukemia, Experimental
72 rdf:type schema:DefinedTerm
73 N1d8b7225fde1496ab674e6a58e28ee61 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
74 schema:name Rats
75 rdf:type schema:DefinedTerm
76 N218f24fd2ec0472e8fa1bf90fba6915b schema:volumeNumber 115
77 rdf:type schema:PublicationVolume
78 N2f53f0cbd373497c93472d2576b301ad schema:name Department of Experimental Cancer Research, ASTA Pharma AG, D-4800, Bielefeld 14, Federal Republic of Germany
79 rdf:type schema:Organization
80 N3bcaf7bc7f2043dab58bbd96800e7307 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Male
82 rdf:type schema:DefinedTerm
83 N44250bd86e674ba9bb6d8e82e7cb8361 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Cyclophosphamide
85 rdf:type schema:DefinedTerm
86 N451574304078481f8dc6c25300b1a5e0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Ovarian Neoplasms
88 rdf:type schema:DefinedTerm
89 N4e18727c479d49ed96c4a8a0c4c21adb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Neoplasm Transplantation
91 rdf:type schema:DefinedTerm
92 N558f9b205a0b4ba0a7a8379de066bc89 rdf:first sg:person.01023655171.21
93 rdf:rest Nd4b7b07ccfb34c84be9d7dce79eff997
94 N62b73f8678de45dcb5e6a2f8496c012a rdf:first sg:person.01340535776.53
95 rdf:rest N558f9b205a0b4ba0a7a8379de066bc89
96 N68374052020c436bbb57d277aa976860 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Cytotoxicity, Immunologic
98 rdf:type schema:DefinedTerm
99 N6f9880a502cc4b939934dacaea6e56f6 schema:name readcube_id
100 schema:value 0606c90f1eab6102a69eadaa320ae571091630d59c0e780247e7f5c5b488fa80
101 rdf:type schema:PropertyValue
102 N8715cba4a3ee4faab9a72d404675299d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Animals
104 rdf:type schema:DefinedTerm
105 N8d152d3daf3f4f19b75ba83c81d94d73 schema:affiliation https://www.grid.ac/institutes/grid.7497.d
106 schema:familyName Zeller
107 schema:givenName Jens
108 rdf:type schema:Person
109 Na69f3e95d8034dec83027315292c4743 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Plasmacytoma
111 rdf:type schema:DefinedTerm
112 Nad26b17d9a8841a9a910865a711f0bdc rdf:first N8d152d3daf3f4f19b75ba83c81d94d73
113 rdf:rest rdf:nil
114 Naffdf794cb32424a8e0dbbfa5e97568b schema:name Springer Nature - SN SciGraph project
115 rdf:type schema:Organization
116 Nb975b8467fef4e64adfcb9b601445fb8 schema:name dimensions_id
117 schema:value pub.1001265313
118 rdf:type schema:PropertyValue
119 Nbe046f89f97c41f49ede079c837b727c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Cyclosporins
121 rdf:type schema:DefinedTerm
122 Nc79dfdb85d4b4f0e8adea88061a9fef0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Female
124 rdf:type schema:DefinedTerm
125 Nc80d4b6122d84a39a69452839dafb1cc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Killer Cells, Natural
127 rdf:type schema:DefinedTerm
128 Nc8234753752c497cbf2252597d10c934 schema:issueNumber 6
129 rdf:type schema:PublicationIssue
130 Nc8776455244248f6b94d824bdae46980 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Tumor Cells, Cultured
132 rdf:type schema:DefinedTerm
133 Nca8ff02c795f4ce8a9b5cd39e40cf42a schema:name Department of Experimental Cancer Research, ASTA Pharma AG, D-4800, Bielefeld 14, Federal Republic of Germany
134 rdf:type schema:Organization
135 Nd2f2bac8c60c40b1b98d048e2c37a90b schema:name pubmed_id
136 schema:value 2606928
137 rdf:type schema:PropertyValue
138 Nd4b7b07ccfb34c84be9d7dce79eff997 rdf:first sg:person.0633453775.54
139 rdf:rest Nad26b17d9a8841a9a910865a711f0bdc
140 Nd851f0527d6640eaac9e41b7eea1d133 schema:name nlm_unique_id
141 schema:value 7902060
142 rdf:type schema:PropertyValue
143 Ne3028014ef3e415e9a16fdee78608d59 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Mice, Inbred Strains
145 rdf:type schema:DefinedTerm
146 Ne653a2eb56d142bd844d6bec0e9a7791 schema:name doi
147 schema:value 10.1007/bf00391352
148 rdf:type schema:PropertyValue
149 Ne8d4a28561954ddca4bde60c6334b6ab schema:name Department of Experimental Cancer Research, ASTA Pharma AG, D-4800, Bielefeld 14, Federal Republic of Germany
150 rdf:type schema:Organization
151 Nf05e47c4f6614a22a8900c2ff0713710 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Mice, Nude
153 rdf:type schema:DefinedTerm
154 Nf94e8de29dde4304a0484e083deb609f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Mice
156 rdf:type schema:DefinedTerm
157 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
158 schema:name Medical and Health Sciences
159 rdf:type schema:DefinedTerm
160 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
161 schema:name Immunology
162 rdf:type schema:DefinedTerm
163 sg:journal.1313647 schema:issn 0171-5216
164 1432-1335
165 schema:name Journal of Cancer Research and Clinical Oncology
166 rdf:type schema:Periodical
167 sg:person.01023655171.21 schema:affiliation Ne8d4a28561954ddca4bde60c6334b6ab
168 schema:familyName Hilgard
169 schema:givenName Peter
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023655171.21
171 rdf:type schema:Person
172 sg:person.01340535776.53 schema:affiliation N2f53f0cbd373497c93472d2576b301ad
173 schema:familyName Reissmann
174 schema:givenName Thomas
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340535776.53
176 rdf:type schema:Person
177 sg:person.0633453775.54 schema:affiliation Nca8ff02c795f4ce8a9b5cd39e40cf42a
178 schema:familyName Voegeli
179 schema:givenName Rainer
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0633453775.54
181 rdf:type schema:Person
182 sg:pub.10.1007/bf00047471 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046220680
183 https://doi.org/10.1007/bf00047471
184 rdf:type schema:CreativeWork
185 sg:pub.10.1007/bf00204986 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025873521
186 https://doi.org/10.1007/bf00204986
187 rdf:type schema:CreativeWork
188 sg:pub.10.1007/bf00205439 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035713745
189 https://doi.org/10.1007/bf00205439
190 rdf:type schema:CreativeWork
191 sg:pub.10.1007/bf00205559 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052450309
192 https://doi.org/10.1007/bf00205559
193 rdf:type schema:CreativeWork
194 sg:pub.10.1007/bf01631649 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000151847
195 https://doi.org/10.1007/bf01631649
196 rdf:type schema:CreativeWork
197 sg:pub.10.1038/262077a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053098476
198 https://doi.org/10.1038/262077a0
199 rdf:type schema:CreativeWork
200 sg:pub.10.1038/278451a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013138905
201 https://doi.org/10.1038/278451a0
202 rdf:type schema:CreativeWork
203 https://app.dimensions.ai/details/publication/pub.1079645222 schema:CreativeWork
204 https://app.dimensions.ai/details/publication/pub.1079661323 schema:CreativeWork
205 https://app.dimensions.ai/details/publication/pub.1079719452 schema:CreativeWork
206 https://app.dimensions.ai/details/publication/pub.1079745935 schema:CreativeWork
207 https://app.dimensions.ai/details/publication/pub.1079909305 schema:CreativeWork
208 https://app.dimensions.ai/details/publication/pub.1080029033 schema:CreativeWork
209 https://app.dimensions.ai/details/publication/pub.1081632263 schema:CreativeWork
210 https://app.dimensions.ai/details/publication/pub.1082079384 schema:CreativeWork
211 https://app.dimensions.ai/details/publication/pub.1082165067 schema:CreativeWork
212 https://app.dimensions.ai/details/publication/pub.1082270364 schema:CreativeWork
213 https://doi.org/10.1002/1097-0142(19860615)57:12<2309::aid-cncr2820571212>3.0.co;2-h schema:sameAs https://app.dimensions.ai/details/publication/pub.1004798902
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1002/ijc.2910150408 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002471216
216 rdf:type schema:CreativeWork
217 https://doi.org/10.1016/0192-0561(85)90016-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009463786
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1016/0192-0561(86)90098-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026508026
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1084/jem.155.1.276 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012689937
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1084/jem.161.5.1249 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031090006
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1093/jnci/78.4.735 schema:sameAs https://app.dimensions.ai/details/publication/pub.1079768676
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1126/science.7025208 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062643291
228 rdf:type schema:CreativeWork
229 https://www.grid.ac/institutes/grid.7497.d schema:alternateName German Cancer Research Center
230 schema:name Institute for Toxicology and Chemotherapy, Deutsches Krebsforschungszentrum, D-6900, Heidelberg, Federal Republic of Germany
231 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...